1. Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study). Issue 1 (January 2017) Authors: Nakamura, T.; Fukunaga, M.; Nakano, T.; Kishimoto, H.; Ito, M.; Hagino, H.; Sone, T.; Taguchi, A.; Tanaka, S.; Ohashi, M.; Ota, Y.; Shiraki, M. Journal: Osteoporosis international Issue: Volume 28:Issue 1(2017) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗